Aileron Therapeutics, Inc.ALRNNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank36
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-22.29M
Near historical average
Percentile
P36
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-21.28M
Historical baseline
PeriodValueYoY Change
2024$-22.29M-12.5%
2023$-19.81M+20.3%
2022$-24.86M-4.7%
2021$-23.75M-16.0%
2020$-20.48M+22.7%
2019$-26.47M+5.2%
2018$-27.93M-36.0%
2017$-20.53M-36.7%
2016$-15.01M-28.2%
2015$-11.71M-